Rosuvastatin used for
Pro Research Analysisby 
Searched over 200M research papers
Rosuvastatin: Uses and Clinical Efficacy
Management of Hyperlipidemia
Lipid-Lowering Effects
Rosuvastatin is primarily used to manage hyperlipidemia by reducing elevated levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C) in patients with primary hypercholesterolemia, mixed dyslipidemia, and homozygous familial hypercholesterolemia Cheng2004Davidson2002. Clinical studies have shown that rosuvastatin can reduce LDL-C by 43% to 63%, which is more potent compared to other statins like atorvastatin, simvastatin, pravastatin, lovastatin, and fluvastatin Cheng2004Davidson2002. Additionally, rosuvastatin has been found to increase HDL-C by approximately 10%, which is higher than the increase observed with other statins .
Tolerability and Drug Interactions
Rosuvastatin is well tolerated, with incidences of myopathy and liver function test abnormalities being rare and comparable to those of other statins . Unlike many other statins, rosuvastatin is not metabolized by the cytochrome P-450 enzymes, resulting in fewer clinically significant drug interactions Cheng2004Davidson2002.
Cardiovascular Disease Prevention
Primary Prevention
Rosuvastatin has been shown to be effective in the primary prevention of cardiovascular disease (CVD) in patients with no clinical evidence of coronary heart disease but who are at increased risk due to factors such as age and elevated levels of high-sensitivity C-reactive protein (hsCRP) . The JUPITER trial demonstrated that rosuvastatin significantly reduced the occurrence of first major cardiovascular events in apparently healthy individuals with normal LDL-C levels but elevated hsCRP levels Everett2010Carter2010. This trial also showed a 48% reduction in the hazard of fatal and nonfatal stroke among these individuals .
Secondary Prevention
In secondary prevention, rosuvastatin has been shown to delay the progression of atherosclerosis and even cause regression in patients with established coronary heart disease (CHD) . The ASTEROID trial supported the use of intensive lipid-lowering therapy with rosuvastatin in secondary prevention patients, although it remains to be established whether atherosclerotic regression translates into improved cardiovascular outcomes .
Neuroprotective and Anti-Inflammatory Properties
Nerve Regeneration
Rosuvastatin has demonstrated neuroprotective properties in preclinical studies. For instance, it has been shown to enhance functional recovery after sciatic nerve injury in rats, likely due to its antioxidant and anti-inflammatory activities . Chronic administration of rosuvastatin significantly promoted nerve regeneration and accelerated motor function recovery in these animal models .
Brain Injury
Rosuvastatin has also been found to ameliorate early brain injury after subarachnoid hemorrhage in rats by suppressing superoxide formation and nuclear factor-kappa B (NF-κB) activation, thereby reducing oxidative stress and inflammation .
Atherosclerosis and Myocardial Fibrosis
Antiatherosclerotic Effects
Rosuvastatin has been shown to reduce aortic sinus and coronary artery atherosclerosis in SR-B1/apoE double knockout mice, independently of plasma cholesterol lowering . This effect is attributed to the drug's ability to reduce oxidized phospholipids in atherosclerotic plaques and inhibit macrophage foam cell formation .
Myocardial Fibrosis
In the same mouse model, rosuvastatin treatment was associated with decreased cardiac fibrosis and cardiomegaly, further supporting its protective role against cardiovascular complications .
Conclusion
Rosuvastatin is a highly efficacious statin used primarily for managing hyperlipidemia and preventing cardiovascular disease. Its potent lipid-lowering effects, combined with its anti-inflammatory and antioxidant properties, make it a valuable option for both primary and secondary prevention of cardiovascular events. Additionally, its neuroprotective effects and ability to reduce atherosclerosis and myocardial fibrosis highlight its potential benefits beyond lipid management. Further research is needed to fully understand the mechanisms behind these benefits and to confirm their clinical significance.
Sources and full results
Most relevant research papers on this topic
Rosuvastatin in the management of hyperlipidemia.
Rosuvastatin effectively lowers LDL-C levels and raises HDL-C levels, enabling more patients to achieve optimal cholesterol levels with lower doses, reducing the need for dose titration or combination therapy.
Rosuvastatin enhanced functional recovery after sciatic nerve injury in the rat.
Rosuvastatin promotes nerve regeneration and accelerates motor function recovery after sciatic nerve injury in rats, potentially due to its antioxidant and anti-inflammatory properties.
Rosuvastatin ameliorates early brain injury after subarachnoid hemorrhage via suppression of superoxide formation and nuclear factor-kappa B activation in rats.
Rosuvastatin pretreatment improves early brain injury after subarachnoid hemorrhage by reducing oxidative stress and NF-B-mediated inflammation in rats.
DOI